Brief: 2Seventy Bio Q3 Basic EPS USD -1.4
14/11/2023 12:00
Nov 14 (Reuters) - 2Seventy Bio Q3 net income USD -71.638 million. * Q3 pretax profit USD -71.638 million * Q3 operating income USD -77.968 million * Q3 operating expenses USD 90.002 million
Recent news on 2Seventy Bio
See all news2Seventy Bio Inc expected to post a loss of 17 cents a share - Earnings Preview
2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 2Seventy Bio Q4 Basic EPS USD -0.37
2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney